Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Plasma cell 1Lymphoid 1CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 16Lung Neoplasms 5Adenocarcinoma of Lung 5Neoplasms 3Lymphoma, Large-Cell, Anaplastic 3Granuloma, Plasma Cell 3Hematologic Neoplasms 2Tumors Characterized by Genetic Alterations in Anaplastic Lymphoma Kinase (ALK) 1Rhabdomyosarcoma 1Neuroblastoma 1Lymphoma, B-Cell 1Glioblastoma 1Cholangiocarcinoma 1Brain Neoplasms 1Adenocarcinoma Of Esophagus 1ALK-positive NSCLC 1ALK-positive Advanced Tumors 1

Interventions

Temozolomide 4Irinotecan 4eribulin 2Topotecan 2LY2940680 2technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran 1surufatinib 1sonidegib 1soblidotin 1ribociclib 1regorafenib 1pegfilgrastim 1palbociclib 1omburtamab I-131 1lenvatinib 1iso-sulfan blue 1dostarlimab 1dinutuximab 1copanlisib 1cixutumumab 1ceritinib 1bempegaldesleukin 1amino-acid, glucose, and electrolyte solution 1abemaciclib 1Vincristine 1Pemetrexed 1Nivolumab 1Granulocyte-Macrophage Colony-Stimulating Factor 1Gemcitabine 1Everolimus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Rhabdomyosarcoma × ceritinib × Clear all
NCT01742286 2020-06-09

Phase I Study of LDK378 in Pediatric, Malignancies With a Genetic Alteration in Anaplastic Lymphoma Kinase (ALK)

Novartis

Phase 1 Completed
83 enrolled 30 charts
CNSLymphoidPlasma cellSarcoma

Granuloma, Plasma Cell, Neoplasms, Neuroblastoma, Rhabdomyosarcoma, Lymphoma, Large-Cell, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡